Dr. Daragh Heitzman

Dr. Heitzman completed his medical degree at Texas Tech University Health Sciences Center. He finished his neurology training at the University of Texas Southwestern Medical Center at Dallas from 1990-1993, serving as Chief Resident from 1992-1993. He completed a fellowship in EMG, neuromuscular disease and neurophysiology at the Cleveland Clinic in Cleveland, Ohio from 1993-1994. He currently holds positions at Baylor University Medical Center at Dallas and the University of Texas Southwestern Medical Center at Dallas. Dr. Heitzman is a Fellow with the American Academy of Neurology. Dr. Heitzman practices general neurology, but has particular interests in ALS, peripheral nerve and muscle problems, EMG and the use of botulinum toxins (cervical dystonia, hemifacial spasm, blepharospasm, sialorrhea and spasticity). He is director of the ALS / Motor Neuron Disorder Clinic at Texas Neurology sponsored by the Muscular Dystrophy Association (MDA). He is currently participating in multiple clinical drug trials for neurologic diseases.

Dr. Heitzman is rated as an Advanced provider by MediFind in the treatment of Myoclonus-Dystonia. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Dysarthria, and Spinal Muscular Atrophy (SMA).

His clinical research consists of co-authoring 32 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.